Anthony Burgett

---

Publications & Presentations

6. Burgett A W. Single Cell Mass Spectrometry Quantification of Anticancer Drugs: Proof of Concept in Cancer Patients. ACS Pharmacology and Translational Research . 2021; 4 : 96-100

7. Burgett A. Crystal structures of glutathione- and inhibitor-bound human GGT1: critical interactions within the cysteinylglycine binding site. Journal of Biological Chemistry . 2021; 296 : 100066

8. Burgett A. Indole C6 Functionalization of Tryprostatin B Using Prenyltransferase CdpNPT. Catalysts . 2020; 10

Grants

1. Taking Ovarian Cancer Maintenance Therapy to the Next Level, Partnering-PI. DOD. Start Date: 2023. End Date: 2027.

2. Neuropeptide modulation of cerebral blood flow to improve neurological and psychological outcomes following TBI in the presence. DOD. Start Date: 2023. End Date: 2027.

3. Cellular Mechanism of Oxysterol-Binding Protein (OSBP) in Viral Proliferation: A Chemical Biology Approach. NIH. Start Date: 2021. End Date: 2026.

4. Medicinal Chemistry and Drug Development of Broad Spectrum Antiviral Compounds Targeting OSBP. Misc Non-Federal. Start Date: 2026. End Date: 2026.

5. Acquisition of Multicellular Organoid/Spheroid Dispensing Instrument for Oklahoma. Misc Non-Federal. Start Date: 2024. End Date: 2024.

Awards and Honors

1. Susan G. Komen for the Cure Foundation Postdoctoral Fellow. Date: 2007.

Education

1. Degree: Post. Harvard University. Date: 2012.


2. Degree: Ph D. . Date: 2006.


3. Degree: BS. University of Oklahoma. Date: 1999.


4. Degree: BS. University of Oklahoma. Date: 1999.

Administrative Assignments

no results